← Company directory

Later stage / growth

Big Health

Prescription digital therapeutics (sleep & mental health — Sleepio/Daylight)

CandidateSeries CLondon (dual HQ with San Francisco — flagged as ambiguous vs. UK-HQ scope)

Latest disclosed round

Series C

Date
2022-01-01
Amount
USD 75m
Sector
Healthtech & digital health
Companies House
06780612

Evidence status

Review retained

Identity
Candidate
Match
High candidate
Operating status
active
Data origins
Core directory, Growth Network, Live Chris T D1

Capital network

8 linked investors

Funding record

1 disclosed round

DateStageAmountInvestors
2022-01-01Series C$75MSoftBank Vision Fund 2, ArrowMark Partners, Octopus Ventures, Gilde Healthcare, Kaiser Permanente Ventures, Morningside Ventures

Traceability

Source trail

Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.